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Abstract
Background: Acute respiratory distress syndrome (ARDS) is characterized by a noncardiogenic pulmonary edema
with bilateral chest X-ray opacities and reduction in lung compliance, and the hallmark of the syndrome is
hypoxemia refractory to oxygen therapy. Severe hypoxemia (PaO2/FiO2 < 100 mmHg), which defines severe ARDS,
can be found in 20–30 % of the patients and is associated with the highest mortality rate. Although the standard
supportive treatment remains mechanical ventilation (noninvasive and invasive), possible adjuvant therapies can be
considered. We performed an up-to-date clinical review of the possible available strategies for ARDS patients with
severe hypoxemia.
Main results: In summary, in moderate-to-severe ARDS or in the presence of other organ failure, noninvasive
ventilatory support presents a high risk of failure: in those cases the risk/benefit of delayed mechanical ventilation
should be evaluated carefully. Tailoring mechanical ventilation to the individual patient is fundamental to reduce
the risk of ventilation-induced lung injury (VILI): it is mandatory to apply a low tidal volume, while the optimal level
of positive end-expiratory pressure should be selected after a stratification of the severity of the disease, also taking
into account lung recruitability; monitoring transpulmonary pressure or airway driving pressure can help to avoid
lung overstress. Targeting oxygenation of 88–92 % and tolerating a moderate level of hypercapnia are a safe
choice. Neuromuscular blocking agents (NMBAs) are useful to maintain patient–ventilation synchrony in the first
hours; prone positioning improves oxygenation in most cases and promotes a more homogeneous distribution of
ventilation, reducing the risk of VILI; both treatments, also in combination, are associated with an improvement in
outcome if applied in the acute phase in the most severe cases. The use of extracorporeal membrane oxygenation
(ECMO) in severe ARDS is increasing worldwide, but because of a lack of randomized trials is still considered a
rescue therapy.
Conclusion: Severe ARDS patients should receive a holistic framework of respiratory and hemodynamic support
aimed to ensure adequate gas exchange while minimizing the risk of VILI, by promoting lung recruitment and
setting protective mechanical ventilation. In the most severe cases, NMBAs, prone positioning, and ECMO should be
considered.
Background
Since the first description, acute respiratory distress
syndrome (ARDS) has been redefined several times in
order to ameliorate the accuracy of the clinical diag-
nosis [1–3]. However, independently from the differ-
ent proposed definitions, the hallmark of ARDS is the
arterial hypoxemia refractory to the oxygen therapy,
due to pulmonary shunt. Two thresholds for severe
hypoxemia (PaO2/FiO2 < 150 or 100 mmHg) have
been proposed; both of these are associated with the
highest mortality (up to 45 %), duration of mechan-
ical ventilation, and risk of ventilation-induced lung
injury (VILI) [3–5].
According to the recent Berlin definition, ARDS is
characterized by an inflammatory lung edema of recent
onset, causing severe respiratory failure which requires
invasive ventilation or noninvasive ventilation (NIV) [3].
Classically, the increases in lung edema (i.e., lung
weight) and in pleural pressure, raising the hydrostatic
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pressure transmitted throughout the lung, reduce the
lung gas volume and promote the development of nona-
erated regions (consolidated or atelectatic), mainly in the
more dependent lung regions [6].
The increasing knowledge of ARDS pathophysiology
through the years has led to suggestions for the applica-
tion of a lung-protective ventilatory strategy, which in
addition to ensuring adequate oxygenation (PaO2 be-
tween 60 and 80 mmHg) should minimize VILI [3]. Un-
fortunately, completely “safe” lung-protective ventilation
does not exist, and the ventilatory support should be in-
dividualized according to the best compromise among
respiratory mechanics, recruitability, gas exchange, and
hemodynamics.
In this clinical review we will present expert opinion
on the different lung support and adjuvant therapies
which have been proposed within the framework of the
clinical management of ARDS with severe hypoxemia
(i.e., severe ARDS, with PaO2/FiO2 < 100 mmHg).
Noninvasive support
The possible use of NIV in patients with ARDS, al-
though it could reduce the intrapulmonary shunt and
decrease the work of breathing, is still controversial be-
cause of the high risk of failure and the possible risks
associated with a delay in starting invasive mechanical
ventilation. The last consensus conference on NIV
pointed out that “larger controlled studies are required
to determine the potential benefit of adding NIV to
standard medical treatment in the avoidance of endo-
tracheal intubation” [7]. In a recent meta-analysis, which
included 13 studies with a total of 540 patients mainly
treated with bilevel positive airway pressure, the intub-
ation rate ranged between 30 and 86 % and the mortality
rate from 15 to 71 % [8]. Unfortunately, the majority of
these studies were not randomized, the studies presented
great heterogeneity, and none of them compared NIV
with invasive ventilation; consequently, it is not possible
to make firm conclusions. Because of the high risk of
failure, NIV should be reserved for ARDS patients with-
out extralung organ failures, and should be provided in
the ICU where strict monitoring and prompt intubation
is always possible without delay. If after the first few
hours there is no significant improvement in gas ex-
change or the respiratory rate, NIV should be stopped
and invasive mechanical ventilation should be started.
A possible alternative to NIV could be application of
the high-flow nasal cannula (HFNC) system, which can
deliver a very high, heated, and humidified oxygen flow
through the nose [9]. HFNCs are able to increase the
end-expiratory lung volume, reduce the work of breath-
ing, and improve CO2 clearance and oxygenation. In
addition to these beneficial effects, and contrary to NIV,
HFNCs do not require any nasal or mask interface,
which significantly improves long-term tolerance and
use. HFNCs, originally developed for neonatal and
pediatric settings, have been evaluated recently in adult
patients. In an observational study in ARDS patients
(33 % and 29 % with severe and moderate ARDS re-
spectively), HFNCs failed in 40 % of the patients, who
were subsequently intubated [10]. The main reasons for
intubation included worsening of hypoxemia and
hemodynamic or neurologic failure [10]. This rate of in-
tubation was similar to that found by Antonelli et al.
(46 %), who tested NIV in ARDS patients [11]. Presently,
only one randomized study in patients with acute respira-
tory failure without cardiogenic edema has evaluated
HFNCs (with gas flow rate of 50 l/minute) compared with
NIV (set with a pressure support to ensure a tidal volume
between 7 and 10 ml/kg and positive end-expiratory pres-
sure (PEEP) between 2 and 10 cmH2O) and oxygen ther-
apy [12]. The intubation rate was not different between
the three groups (from 38 to 50 %), but the intensive care
mortality was significantly lower in the HFNC group.
Presently the indications and the standards of moni-
toring for HFNCs in ARDS patients are similar to those
of NIV.
PEEP and lung recruitment
Although PEEP and lung recruitment are usually consid-
ered separately in the lung-protective ventilation proto-
cols, they are strictly related. Accordingly to a physical
model, in order to recruit the lung (i.e., to inflate the
collapsed lung regions) and to keep these regions open,
we have to overcome the superimposed pressure gener-
ated by the lung mass and by the chest wall [13]. To re-
cruit the lung, several types of recruitment maneuvers
(RMs) have been proposed: the sigh, in which higher
tidal volumes are intermittently delivered during ventila-
tion; the sustained inflation, induced by a static increase
in airway pressure applied for 20–40 seconds; and the
extended sigh, in which a stepwise increase of PEEP is
applied [14]. Independently of the applied RMs, the
main goal is to reinflate the “closed” pulmonary units by
applying a high transpulmonary pressure for an adequate
period of time. In the majority of patients, a RM is able
to improve oxygenation for a certain period of time
without major side effects [14]; however, the RMs alone
were not associated with a reduction in mortality [15].
During the decades, the “philosophy” of PEEP has
changed significantly. From a simple tool used to in-
crease oxygenation at the beginning of the history of
mechanical ventilation, PEEP has in recent years gained
a primary role in the framework of the lung-protective
strategy, avoiding intratidal opening and closing and de-
creasing lung inhomogeneities [4, 16–18]. Owing to the
different amounts of lung edema, the total lung recruit-
ability (estimated by lung computed tomography (CT)
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scan) was found to range from 0 to 70 % of the total
lung weight [19] (Fig. 1). Presently, although the lung
CT scan requires the transport of patients outside the
ICU and the use of X-ray radiation, it remains the gold
standard to compute lung recruitability [20, 21]. The use
of a visual scale to estimate lung recruitment and the ap-
plication of a low-dose protocol for CT scan acquisition
have shown promising results [22, 23]. In addition, a re-
cent observational study showed that the CT scan, inde-
pendent from estimation of lung recruitment, contributed
to diagnosis in 53 % of patients and induced a therapeutic
change in 54 % of cases [24]. As an alternative, lung ultra-
sound showed a reliable accuracy in estimating lung
recruitability, but further studies are necessary to confirm
its use [25].
Although several experimental and observational
studies found a beneficial effect for the use of higher
PEEP in ARDS [19, 26, 27], the three most recent
randomized trials (ALVEOLI, ExPress, and LOV) did
not show any difference in outcome between a low
and a high PEEP ventilator strategy [28–30]. However,
when combining these data considering only the subgroup
of the most severe patients (PaO2/FiO2 < 200 mmHg), the
use of higher PEEP level significantly decreased mortality
[31, 32]. This suggests that the greater the severity (and
the higher the amount of lung edema), the higher the
positive effect of PEEP in reducing VILI. This has also
been confirmed in an observational study, in which higher
PEEP levels significantly reduced the opening and closing
effects only in patients with higher recruitability [16].
However, the relationship between lung edema/mass and
recruitability has been questioned by Cressoni et al. [13],
who found that the PEEP levels necessary to keep the lung
open are independent from total lung recruitability. These
results suggest that recruitability depends also on the na-
ture of edema, time of onset, and distribution of the dis-
ease within the lung parenchyma.
Several approaches have been proposed to tailor PEEP
for the individual patient. The most common approach
is to titrate PEEP according to an oxygenation/saturation
target based on a PEEP/FiO2 table [30]. An alternative
method, based on respiratory mechanics, is to increase
PEEP by maintaining a constant tidal volume, not over-
coming a safe limit of airway pressure (26–28 cmH2O)
[28], or, after a RM, to decrease PEEP until a reduction
of compliance appears [33, 34]. Despite the possible un-
certainties regarding the end-expiratory absolute esopha-
geal pressure as a reliable estimation of the pleural
pressure [35], Talmor et al. [36] showed a better oxygen-
ation and compliance when PEEP was set according to
an end-expiratory transpulmonary pressure between 0
and 10 cmH2O (absolute method). Alternative to the ab-
solute value, the changes in esophageal pressure due to
PEEP and tidal volume (elastance method) have been
used to compute the total end-inspiratory transpulmon-
ary pressure, as a better marker of lung stress compared
with airway inspiratory pressure in the presence of alter-
ation in chest wall elastance [37]. By computing the end-
inspiratory transpulmonary pressure vs airway pressure,
Grasso et al. [38] showed that it was possible to increase
High lung recruitability
5 cmH2O 45 cmH2O
Low lung recruitability 
Fig. 1 Example of lung CT scan of patients with high (upper panel) or low (lower panel) potential of lung recruitment
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PEEP, improving oxygenation and avoiding extracorpor-
eal membrane oxygenation (ECMO) support without
overcoming the lung stress. However, when these two
methods (absolute and elastance) were compared, the
resulting PEEP levels were significantly discordant and
furthermore the recommended PEEP changes were in
the opposite direction in up to 30 % of the patients [39].
Recently our group compared the previous published
methods for selecting PEEP (based on gas exchange, re-
spiratory mechanics, and transpulmonary pressure) with
lung recruitability and severity of the disease [40]. The
method based on gas exchange (i.e., FiO2/PEEP table of
the LOV study [30]) was the only one which provided
PEEP levels according to the severity of the disease; on
the contrary, the other methods suggested similar levels
of PEEP that were not related to the severity or to lung
recruitability [40]. Interestingly, obese patients with
ARDS presented a significantly lower lung gas volume
but similar lung recruitability and chest wall elastance
compared with normal body weight patients [41].
Based on the available data, it is clear that “perfect
PEEP”—which can simultaneously provide the best oxy-
genation, compliance, and reduction of VILI—does not
exist. Therefore, we suggest performing, in the acute
phase, a stratification of patients according to the sever-
ity of ARDS before any PEEP selection. This can be done
easily by ventilating the patient with pure oxygen at
PEEP 5 cmH2O [5]. In the case of severe ARDS, the lung
recruitability should be computed by lung CT scan or
lung ultrasound, and high PEEP levels (i.e., >15 cmH2O)
following the PEEP/FiO2 table of the LOV study [30]
should be applied. On the contrary, in mild to moderate
ARDS, low PEEP levels (<10 cmH2O) can be applied
safely.
Improvement in oxygenation can be due simply to a
hemodynamic effect (reduction of cardiac output and
right-to-left shunt) without any effect on lung recruit-
ment. Thus, before any PEEP trial the patients should
present hemodynamic stability, and any changes in
hemodynamics during the trial should be evaluated. In
addition, to avoid lung overstress, the transpulmonary
pressure should be measured while simultaneously titrat-
ing PEEP and the tidal volume.
Tidal volume
One of the main determinants of VILI is the generation
of an unphysiologic stress (tension) and strain (deform-
ation), which depends both on the size of the delivered
tidal volume and the amount of lung resting volume
[42]. The lower the tidal volume and/or the higher the
resting volume, the lower will be the generated stress/
strain, which is associated with lung damage irrespective
of hypercapnia [37, 43]. Basing on these findings, a sem-
inal study (the ARMA trial) showed a reduction of 22 %
in mortality using a tidal volume of 6 ml/kg of ideal
body weight compared with 12 ml/kg [44]. A recent
Cochrane Collaboration meta-analysis considering the
randomized controlled trials which compared ventilation
using either a lower tidal volume or lower airway pressure
(i.e., plateau pressure ≤ 30 cmH2O) with a ventilation
using a higher tidal volume clearly showed that mortality
at day 28 was significantly reduced by lung-protective ven-
tilation [45]. The authors thus concluded that ventilation
with lower tidal volumes should become a routine strategy
treatment for ARDS, stopping the investigators from car-
rying out additional trials. However, despite almost two
decades since the publication of the ARMA trial, the low
tidal volume is still not used routinely [46], although it has
also been proved that this strategy is clinically safe without
the need for an increase in the dosage of sedative or
neuromuscular blockers [47, 48].
Usually tidal volume is selected according to ideal
body weight; however, ideal body weight is poorly related
to the resting volume, and a similar tidal volume can
generate different lung stress/strain in different patients
with the same anthropometric characteristics [37]. Re-
cently, the use of airway driving pressure has been pro-
posed to better individualize the tidal volume [49]. The
airway driving pressure, measured as the ratio between
the tidal volume and respiratory system compliance,
should better reflect lung stress/strain because the re-
spiratory system compliance is related to the available
lung gas volume [50, 51]. Recently, Amato et al. [49]
found that the airway driving pressure, in different com-
binations of tidal volume and levels of PEEP, was the
strongest factor associated with outcome in ARDS pa-
tients. The airway driving pressure could thus be a use-
ful tool to identify patients at risk of VILI.
Modality of mechanical ventilation
Presently the two most commonly used modes of
mechanical ventilation are pressure-controlled ventila-
tion (PCV) and volume-controlled ventilation (VCV).
With PCV the delivered volume changes according to
the characteristics of the respiratory system, and the in-
spiratory flow presents a decelerating shape; in VCV the
delivered volume remains constant, while the airway
pressure is variable and the inspiratory flow has a con-
stant shape. It has been hypothesized that PCV could
present higher benefits in reducing VILI, due to deceler-
ating inspiratory flow and the changes in delivered tidal
volume according to the patient’s disease. In order to as-
sess any possible advantage of PCV compared with VCV,
Chacko et al. [52] performed a systematic review and
meta-analysis without showing any difference in mortal-
ity or risk of barotrauma between the two modes.
Compared with controlled mechanical ventilation,
assisted mechanical ventilation could provide some
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beneficial effects by reducing the level of sedation, main-
taining the respiratory muscle activity, and promoting a
more homogeneous distribution of the ventilation [53]. In
a small cross-over study of moderate ARDS, similar tidal
volumes and lung distending pressure were found among
pressure support ventilation (PSV), PCV, and neurally ad-
justed ventilatory assist (NAVA) [54]. When not properly
applied, however, the use of assisted mechanical ventila-
tion in severe ARDS, similarly to NIV, could negatively
affect the outcome and increase VILI by increasing the
transpulmonary pressure, work of breathing, and rapid
shallow breathing [53]. Further studies are required to
clarify the role of PSV and NAVA in severe ARDS.
Oxygenation and CO2 target
The commonly recommended oxygenation target ranges
between 88 and 95 %. However, in clinical practice a
more liberal approach aimed to maintain an arterial sat-
uration higher than 96 % is often used, due to physician
perception of higher patient safety. To better understand
the possible benefits of a more liberal strategy, Panwar
et al. [55] randomized ARDS patients to receive an arter-
ial saturation higher than 96 % or between 88 and 92 %.
The liberal strategy did not influence both the number
of organ failures and the outcome.
The application of a low tidal volume ventilation strat-
egy can result in hypercapnia, but does not present
major side effects and is well tolerated. However, hyper-
capnia can increase a patient’s respiratory drive, and was
independently related to the administration of neuro-
muscular blocking agents (NMBAs) [56]. Although the
optimal CO2 level is still unclear, in the absence of right
cardiac failure and raised intracranial pressure up to
70 mmHg of arterial CO2 with a pH of 7.20 has been
found to be safe [57, 58].
Neuromuscular blocking agents
NMBAs are frequently used to abolish the inspiratory
and expiratory efforts of patients, in order to improve
patient–ventilator synchrony and to minimize the
muscle oxygen consumption [59]. In addition, NMBAs
can reduce the stress/strain generated in the lung by re-
ducing the negative increase in pleural pressure during
spontaneous efforts [59]. However, NMBAs can increase
the risk of ICU-acquired weakness and diaphragmatic
dysfunction, prolonging the duration of mechanical ven-
tilation. In the last multicenter randomized trials evalu-
ating PEEP, NMBAs were given in up to one-half of the
enrolled patients [28, 30]. Although NMBAs were ap-
plied without a predefined protocol, they were more fre-
quently used in patients with a higher APACHE III score
and hypoxemia, without any difference between the low
and high PEEP groups [56]. To clarify the role of
NMBAs in ARDS, several trials have been published in
recent years. In 2004 Gainnier et al. [60] evaluated, in
severe ARDS patients, the effects of 48 hours of NMBA
infusion added to a deep sedation (level 6 accordingly to
the Ramsay scale). At 48, 96 and 120 hours the NMBA
group had higher oxygenation without any difference in
the airway plateau pressure, PEEP levels, and amount of
drugs used for sedation. A further small randomized trial
showed that a continuous infusion of NMBAs during
the first 48 hours caused a significantly lower local (pul-
monary) and systemic (blood) inflammatory response
(IL-6 and IL-8), lower PEEP levels, and better oxygen-
ation [61]. In the largest multicenter trial, 340 severe
ARDS patients were randomized to receive a 48-hour
continuous infusion of NMBAs or a placebo [62]. The
NMBA group showed a significant reduction in the
90-day mortality rate, with a higher amount of ventilator-
free days and lower incidence of pneumothorax. The inci-
dence of ICU-acquired paresis at intensive care discharge
was not different. A subsequent meta-analysis, considering
the randomized controlled trials of adult patients with
ARDS randomized to receive NMBAs, found that the pa-
tients treated with NMBAs presented a lower mortality
(risk ratio 0.71 (95 % confidence interval 0.55–0.90)) and
fewer days of mechanical ventilation, with a higher num-
ber of ventilator-free days at day 28 (p = 0.0020) and lower
episodes of barotrauma (p = 0.030) [63].
Based on the available data, NMBAs should be reserved
for the most severe ARDS patients, mainly in the acute
phase and in the first hours of mechanical ventilation, to
ensure adequate patient–ventilator synchrony, avoiding
the generation of a harmful transpulmonary pressure.
However, the adjustment of the ventilator setting and the
need for paralysis should, at least, be evaluated every day.
Prone positioning
More than 30 years ago several observational studies re-
ported that prone positioning was able to increase arter-
ial oxygenation in the majority of patients with acute
respiratory failure [64, 65]. Prone positioning was thus
reserved as a rescue treatment in case of life-threatening
hypoxemia. The main consequences of prone position-
ing, which can be all or in part present, include a redis-
tribution of the lung densities with a recruitment of the
dorsal regions, an increase in the chest wall elastance, a
reduction in the alveolar shunt, and a better ventilation/
perfusion ratio with improvement in oxygenation and
CO2 clearance, a more homogeneous distribution of
ventilation with a reduction of VILI, and a reverse of
right heart failure [66, 67]. Based on these favorable ef-
fects, several trials have been planned since 1996 to test
prone positioning in ARDS patients. The first studies,
enrolling patients with moderate to severe ARDS with-
out applying protective mechanical ventilation, did not
show any beneficial effect from use of short-term prone
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positioning (<8 hours per day) [68, 69]. The subsequent
two trials, which enrolled more severe hypoxemic pa-
tients with a longer period of prone positioning (20 hours
per day), also did not show any beneficial effects [70,
71]; however, a meta-analysis of the previous studies
suggested a significant survival benefit for patients with
PaO2/FiO2 < 140 mmHg at admission [72]. With this
background, Guerin et al. [73] conducted a multicenter
randomized study on the use of long-term prone posi-
tioning (at least 16 hours per day) in severe ARDS. The
PEEP was selected from a PEEP/FiO2 table of the low
PEEP arm of the ALVEOLI study [29] and the tidal
volume was strictly controlled to 6 ml/kg of ideal
body weight. The mortality at 28 days was significantly
lower in the prone positioning group (16 % vs 32 %), the
rate of successful extubation was higher, and the mean
duration of prone positioning was 17 ± 3 hours [73].
Owing to the reduction of the harmful effects of
mechanical ventilation both by prone positioning and
NMBAs when evaluated separately, adding NMBAs in
prone positioning could have a synergistic effect in
improving the oxygenation, decreasing the duration of
mechanical ventilation, and improving the final out-
come [74].
According to the recent Berlin definition, prone posi-
tioning should be reserved for severe ARDS patients, es-
pecially in the acute phase in which the amount of
edema, atelectasis, and lung recruitability is higher, and
for a longer period of time [4]. Although in a minority
of the patients the oxygenation does not improve, prone
positioning has additional beneficial effects, mainly
related to the reduction of VILI, to be considered. Al-
though prone positioning presents some technical issues,
when it is performed by a skilled team the adverse af-
fects are relatively low and they are significantly over-
come by the beneficial effects. However, before any
change in the position of critically ill patients, the pres-
ence of any absolute contraindication (e.g., pregnancy,
unstable fractures, open abdominal wounds, extreme
hemodynamic instability) has to be considered [66].
Extracorporeal membrane oxygenation
Standard ECMO support is commonly performed by a
veno-venous access in which the blood is drained by the
superior or inferior vena cava and reinfused in the right
atrium. The artificial lung is able to provide adequate
blood CO2 removal and oxygenation, allowing reduction
of mechanical ventilation (tidal volume, respiratory rate,
and oxygen fraction) and minimization of VILI. The first
applications of ECMO in patients with acute respiratory
failure did not show any benefit; some years later, start-
ing in 1985, several studies found a decrease in the mor-
tality rate, ranging between 21 and 50 % [75]. However,
only one randomized trial comparing ECMO with
standard care have been performed recently (the
CESAR trial) [76]. In this trial, patients with ARDS
were referred to a single center and managed with ECMO
or treated with conventional mechanical ventilation.
Assess the severity of hypoxemia







Lung CT scan or lung ultrasound to assess lung
recruitability
Optimize PEEP and lung recruitment
Use low tidal volume ventilation
Insure adequate gas exchange
Minimize VILI by monitoring the transpulmonary pressure or driving pressure
Always check hemodinamics
Avoid patient ventilator dyssinchrony by NMBAs
Apply prone position
Consider ECMO
Non-Invasive vs Invasive ventilation
Fig. 2 Simple flow chart for a holistic approach to mechanical ventilation in ARDS patients. CT computed tomography, ECMO extracorporeal
membrane oxygenation, NMBA neuromuscular blocking agents, PEEP positive end-expiratory pressure, VILI ventilation-induced lung injury
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Mechanical ventilation during ECMO provided lung rest
with a peak inspiratory pressure of 20–25 cmH2O and
PEEP between 10 and 15 cmH2O. At 6 months the
ECMO group presented a higher survival rate compared
with the control group (63 % vs 47 %; p = 0.03), while the
quality of life and spirometric parameters were not differ-
ent. Despite these positive results, the CESAR trial has
been criticized because ventilator treatment in the control
group was not standardized, 30 % of the patients were not
ventilated with a lung-protective strategy, and all patients
requiring ECMO were allocated only in one skilled center.
From these data it is thus not possible to conclude that
ECMO is superior to mechanical ventilation [75]. Despite
the absence of any further randomized trial, but mainly
based on the theoretical benefit of lung rest and on several
case series, the use of ECMO has continued to increase
worldwide. However, some uncertainty remains; as an ex-
ample, the recent Scandinavian clinical practice guideline
on mechanical ventilation in ARDS does not take into ac-
count the use of ECMO [77].
To better allocate resource utilization and to help
the physician choose the appropriate treatment, be-
cause of a lack of recognized criteria for ECMO
application, Schmidt et al. [78] in a retrospective ana-
lysis identified eight sample clinical variables collected
at ECMO admission which showed good accuracy to
predict the probability of survival. In a subsequent
study the same author, in a larger database registry of
2355 patients treated with ECMO, identified 12 vari-
ables which allowed creation of a well-calibrated sur-
vival model [79].
It is worthy to remember that VILI is not completely
abolished during ECMO treatment: consequently, prone
positioning—similar to conventional mechanical ventila-
tion—should be used as an adjuvant tool. At the present
time there is a paucity of data regarding the use of prone
positioning during ECMO; for example, the ELSO regis-
try (the largest worldwide) did not collect this informa-
tion (https://www.elso.org/). However, Kimmoun et al.
[80] found that prone positioning for 24 hours, per-
formed in ARDS patients during ECMO, significantly in-
creased oxygenation and respiratory system compliance
in the majority of patients without major adverse effects.
Conclusions
Severe ARDS patients should receive a holistic frame-
work of respiratory and hemodynamic support ensuring
adequate gas exchange and minimizing VILI (Fig. 2):
setting an adequate PEEP level (also considering lung
recruitability) is of fundamental importance, while
avoiding lung overstress by monitoring transpulmonary
pressure (or airway driving pressure) and considering in
the most severe cases NMBAs, prone positioning, and
ECMO (also in combination). The need for NMBAs and
prone positioning should be evaluated daily to avoid
delaying the waking of the patient and the onset of early
mobilization.
Key messages
 Severe hypoxemia is present in up to 30 % of ARDS
patients, and is associated with higher mortality and
longer duration of mechanical ventilation.
 Stratification of the patients is important, in order to
identify those who might benefit from adjunctive
treatments.
 In all patients, a holistic framework of respiratory
and hemodynamic support should be considered.
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